Company record
Aytu Biopharma
2 FDA warning letters since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Aytu Biopharma.
Warning letters
-
DrugsAytu Biopharma
FDA says Aytu Biopharma’s sponsored links for ADHD drug Cotempla XR-ODT are false or misleading and misbrand it.
High risk -
DrugsAytu Biopharma
FDA warned Aytu Biopharma that sponsored links for ADHD drug Adzenys XR-ODT are false or misleading because they omit risk information.
High risk